Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY J9000-J9999

2025 HCPCS code J9352

This HCPCS code represents the supply of 0.1 mg of trabectedin, a chemotherapy drug used to treat certain types of sarcoma.

2025 HCPCS code J9022

This HCPCS code represents 10 mg of atezolizumab (Tecentriq), a monoclonal antibody administered intravenously for treating various cancers, including bladder cancer.

2025 HCPCS code J9072

This HCPCS code represents 5 mg of cyclophosphamide from Dr. Reddy's, a cancer medication typically administered intravenously.

2025 HCPCS code J9267

This HCPCS code represents the supply of 1 mg of paclitaxel for intravenous administration.

2025 HCPCS code J9130

Dacarbazine, 100 mg; this HCPCS code represents the supply of the drug only, not its administration.

2025 HCPCS code J9296

This HCPCS code represents 10 mg of pemetrexed (from Accord), a drug used to treat mesothelioma or non-squamous, non-small cell lung cancer.

2025 HCPCS code J9065

HCPCS code J9065 represents the drug cladribine, priced per milligram (mg).

2025 HCPCS code J9285

Injection, olaratumab, 10 mg

2025 HCPCS code J9248

This HCPCS code represents 1 mg of melphalan (Hepzato™), administered intravenously for liver cancer therapy.

2025 HCPCS code J9019

Injection of asparaginase (Erwinaze), 1,000 IU.

2025 HCPCS code J9266

This HCPCS code represents a single-dose vial of pegaspargase, a chemotherapy medication used to inhibit cancer cell growth.

2025 HCPCS code J9215

Injection of interferon alfa-n3 (human leukocyte-derived), 250,000 IU.

2025 HCPCS code J9271

This HCPCS code represents 1 mg of pembrolizumab, a chemotherapy drug administered intravenously.

2025 HCPCS code J9208

This HCPCS code represents the supply of 1 gram of ifosfamide injection, a chemotherapy drug used to inhibit cancer cell growth.

2025 HCPCS code J9293

This HCPCS code represents 5 mg of mitoxantrone hydrochloride, a chemotherapy drug used to inhibit cancer cell growth.

2025 HCPCS code J9393

<a href="../medical-coding/reference/J9395" target="_blank" title="Medical Code J9395 2025">Tiêm, fulvestrant (Teva), 25 mg; không tương đương điều trị với J9395.</a>

2025 HCPCS code J9261

Injection, nelarabine, 50 mg

2025 HCPCS code J9150

Injection, daunorubicin, 10 mg

2025 HCPCS code J9225

Histrelin implant (Vantas), 50 mg. Used to treat early puberty and advanced prostate cancer.

2025 HCPCS code J9207

Injection, ixabepilone, 1 mg

2025 HCPCS code J9171

This HCPCS code represents 1 mg of the chemotherapy drug docetaxel for injection.

2025 HCPCS code J9325

Injection, talimogene laherparepvec, per 1 million plaque-forming units.

2025 HCPCS code J9196

200 mg of gemcitabine hydrochloride (Accord), administered intravenously for various cancers.

2025 HCPCS code J9263

This HCPCS code represents 0.5 mg of oxaliplatin for injection.It covers only the drug, not its administration.

2025 HCPCS code J9203

One unit represents 0.1 mg of gemtuzumab ozogamicin for IV injection in treating AML.

2025 HCPCS code J9301

Injection, obinutuzumab, 10 mg.

2025 HCPCS code J9321

Injection, epcoritamab-bysp, 0.16 mg.

2025 HCPCS code J9371

Vincristine sulfate liposome, injection, 1 mg

2025 HCPCS code J9057

Injection, copanlisib, 1 mg

2025 HCPCS code J9210

Injection, emapalumab-lzsg, 1 mg

2025 HCPCS code J9075

Injection, cyclophosphamide, not otherwise specified, 5 mg.

2025 HCPCS code J9317

Injection, sacituzumab govitecan-hziy, 2.5 mg

2025 HCPCS code J9098

Injection, cytarabine liposome, 10 mg.

2025 HCPCS code J9270

Injection, plicamycin, 2.5 mg

2025 HCPCS code J9074

Injection, cyclophosphamide (sandoz), 5 mg

2025 HCPCS code J9298

Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg.

2025 HCPCS code J9030

BCG live intravesical instillation; 1 mg.

2025 HCPCS code J9313

One unit of J9313 represents 0.01 mg of moxetumomab pasudotox-tdfk administered intravenously to treat relapsed or refractory hairy cell leukemia in adults.

2025 HCPCS code J9355

J9355 represents 10 mg of trastuzumab (excluding biosimilars) for intravenous infusion; it inhibits cancer cell multiplication and spread.

2025 HCPCS code J9333

This HCPCS code represents 1 mg of rozanolixizumab-noli, a drug administered subcutaneously to treat generalized myasthenia gravis.

2025 HCPCS code J9393

Injection, fulvestrant (Teva), 25 mg; not therapeutically equivalent to J9395.

2025 HCPCS code J9332

Injection, efgartigimod alfa-fcab, 2 mg.

2025 HCPCS code J9357

Valrubicin, intravesical, 200 mg injection.

2025 HCPCS code J9055

Injection, cetuximab, 10 mg.

2025 HCPCS code J9227

This HCPCS code represents 10 mg of isatuximab-irfc, a monoclonal antibody administered intravenously, typically used in multiple myeloma treatment.

2025 HCPCS code J9228

Injection, ipilimumab, 1 mg.

2025 HCPCS code J9306

J9306 represents 1 mg of pertuzumab injection.

2025 HCPCS code J9155

Degarelix injection, up to 1 mg.

2025 HCPCS code J9036

This code represents 1 mg of bendamustine hydrochloride (Belrapzo) administered intravenously.

2025 HCPCS code J9309

This HCPCS code represents 1 mg of polatuzumab vedotin-piiq administered intravenously.